Prelude Therapeutics (PRLD) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Prelude Therapeutics (PRLD).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 4.58M (-18.79%) | 5.64M (-13.23%) | 6.50M | - | - | 4.00M (+33.33%) | 3.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 14M (-24.40%) | 18M (-17.13%) | 22M (-15.79%) | 26M (-10.55%) | 29M (-8.86%) | 32M (+7.33%) | 29M (-0.17%) | 30M (+7.66%) | 27M (-9.63%) | 30M (+15.50%) | 26M (+5.17%) | 25M (+14.38%) | 22M (-15.62%) | 26M (+13.02%) | 23M (+7.41%) | 21M (-6.62%) | 23M (-9.37%) | 25M (+10.83%) | 23M (+1.38%) | 22M (+36.07%) | 16M (+13.04%) | 15M (-4.71%) | 15M (+56.34%) | 9.78M (+14.52%) | 8.54M (-54.55%) | 19M (+242.26%) | 5.49M | - | - |
Selling General And Administrative | 5.16M (+3.20%) | 5.00M (-4.03%) | 5.21M (-18.72%) | 6.41M (+10.71%) | 5.79M (-6.76%) | 6.21M (-21.59%) | 7.92M (+3.39%) | 7.66M (+10.53%) | 6.93M (-1.70%) | 7.05M (-0.98%) | 7.12M (-4.17%) | 7.43M (+2.06%) | 7.28M (-3.19%) | 7.52M (0.00%) | 7.52M (-7.73%) | 8.15M (+9.10%) | 7.47M (-4.60%) | 7.83M (-3.57%) | 8.12M (+47.37%) | 5.51M (+0.18%) | 5.50M (+12.94%) | 4.87M (+70.88%) | 2.85M (+71.69%) | 1.66M (+38.33%) | 1.20M (-50.82%) | 2.44M (+75.54%) | 1.39M | - | - |
Operating Expenses | 19M (-18.40%) | 23M (-14.60%) | 27M (-16.37%) | 32M (-6.99%) | 35M (-8.51%) | 38M (+1.20%) | 37M (+0.59%) | 37M (+8.21%) | 34M (-8.13%) | 37M (+11.95%) | 33M (+3.06%) | 32M (+11.26%) | 29M (-12.79%) | 33M (+9.80%) | 30M (+3.22%) | 29M (-2.74%) | 30M (-8.24%) | 33M (+7.04%) | 31M (+10.46%) | 28M (+27.08%) | 22M (+12.96%) | 19M (+7.22%) | 18M (+58.57%) | 11M (+17.45%) | 9.74M (-54.12%) | 21M (+208.58%) | 6.88M | - | - |
Depreciation And Amortization | 390K (-69.53%) | 1.28M | - | - | 440K (-67.41%) | 1.35M | - | - | 430K (-51.69%) | 890K | - | - | 280K (-72.55%) | 1.02M | - | - | 310K (-59.21%) | 760K | - | - | 160K (-60.98%) | 410K | - | - | 130K (-65.79%) | 380K | - | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -14.18M (-18.27%) | -17.35M (-15.03%) | -20.42M (-36.56%) | -32.19M (-6.99%) | -34.61M (+2.31%) | -33.83M (-1.60%) | -34.38M (-7.48%) | -37.16M (+8.21%) | -34.34M (-8.13%) | -37.38M (+11.98%) | -33.38M (+3.02%) | -32.40M (+11.30%) | -29.11M (-12.79%) | -33.38M (+9.77%) | -30.41M (+3.22%) | -29.46M (-2.74%) | -30.29M (-8.24%) | -33.01M (+7.04%) | -30.84M (+10.46%) | -27.92M (+27.08%) | -21.97M (+12.96%) | -19.45M (+7.22%) | -18.14M (+58.57%) | -11.44M (+17.45%) | -9.74M (-54.10%) | -21.22M (+208.43%) | -6.88M | - | - |
Ebit | -14.18M (-18.27%) | -17.35M (-15.03%) | -20.42M (-36.56%) | -32.19M (-6.99%) | -34.61M (+2.31%) | -33.83M (-1.60%) | -34.38M (-7.48%) | -37.16M (+8.21%) | -34.34M (-8.13%) | -37.38M (+11.98%) | -33.38M (+3.02%) | -32.40M (+11.30%) | -29.11M (-12.79%) | -33.38M (+9.77%) | -30.41M (+3.22%) | -29.46M (-2.74%) | -30.29M (-8.24%) | -33.01M (+7.04%) | -30.84M (+10.46%) | -27.92M (+27.08%) | -21.97M (+12.96%) | -19.45M (+7.22%) | -18.14M (+58.57%) | -11.44M (+17.45%) | -9.74M (-6.62%) | -10.43M (+51.60%) | -6.88M (+23.74%) | -5.56M (+6.11%) | -5.24M |
EBITDA | -13.79M (-22.22%) | -17.73M (-10.14%) | -19.73M (-36.82%) | -31.23M (-8.60%) | -34.17M (-7.67%) | -37.01M (+14.69%) | -32.27M (-7.11%) | -34.74M (+2.42%) | -33.92M (-17.73%) | -41.23M (+34.69%) | -30.61M (+0.59%) | -30.43M (+5.51%) | -28.84M (-17.36%) | -34.90M (+16.49%) | -29.96M (+9.46%) | -27.37M (-8.71%) | -29.98M (-10.40%) | -33.46M (+9.03%) | -30.69M (+14.26%) | -26.86M (+23.15%) | -21.81M (+6.65%) | -20.45M (+22.02%) | -16.76M (+46.89%) | -11.41M (+18.85%) | -9.60M (-5.88%) | -10.20M (+51.56%) | -6.73M (+21.04%) | -5.56M (+6.11%) | -5.24M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Other Non Operating Income | 3.79M (-25.25%) | 5.07M (+634.78%) | 690K (-28.13%) | 960K (-61.90%) | 2.52M (-79.90%) | 13M (+494.31%) | 2.11M (-12.81%) | 2.42M (-16.84%) | 2.91M (-72.15%) | 10M (+275.90%) | 2.78M (+41.12%) | 1.97M (+40.71%) | 1.40M (-82.72%) | 8.10M (+1700.00%) | 450K (-78.47%) | 2.09M (+154.88%) | 820K (-59.80%) | 2.04M (+1260.00%) | 150K (-85.85%) | 1.06M (+58.21%) | 670K (-63.39%) | 1.83M (+32.61%) | 1.38M (+4500.00%) | 30K (-86.96%) | 230K (-57.41%) | 540K (+260.00%) | 150K | - | - |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -10.38M (-36.94%) | -16.46M (-16.57%) | -19.73M (-36.82%) | -31.23M (-2.65%) | -32.08M (+11.66%) | -28.73M (-10.97%) | -32.27M (-7.11%) | -34.74M (+10.53%) | -31.43M (-4.99%) | -33.08M (+8.07%) | -30.61M (+0.59%) | -30.43M (+9.78%) | -27.72M (-3.21%) | -28.64M (-4.41%) | -29.96M (+9.46%) | -27.37M (-7.09%) | -29.46M (-10.29%) | -32.84M (+7.01%) | -30.69M (+14.26%) | -26.86M (+26.10%) | -21.30M (+10.65%) | -19.25M (+14.86%) | -16.76M (+46.89%) | -11.41M (+19.98%) | -9.51M (-5.28%) | -10.04M (+49.18%) | -6.73M (+21.04%) | -5.56M (+6.11%) | -5.24M |
Net Income | -10.38M (-36.94%) | -16.46M (-16.57%) | -19.73M (-36.82%) | -31.23M (-2.65%) | -32.08M (+11.66%) | -28.73M (-10.97%) | -32.27M (-7.11%) | -34.74M (+10.53%) | -31.43M (-4.99%) | -33.08M (+8.07%) | -30.61M (+0.59%) | -30.43M (+9.78%) | -27.72M (-3.21%) | -28.64M (-4.41%) | -29.96M (+9.46%) | -27.37M (-7.09%) | -29.46M (-10.29%) | -32.84M (+7.01%) | -30.69M (+14.26%) | -26.86M (+26.10%) | -21.30M (+10.65%) | -19.25M (+14.86%) | -16.76M (+46.89%) | -11.41M (+19.98%) | -9.51M (-5.28%) | -10.04M (+49.18%) | -6.73M (+21.04%) | -5.56M (+6.11%) | -5.24M |
Comprehensive Income Net Of Tax | -10.43M (-89.52%) | -99.52M (+404.67%) | -19.72M (-36.88%) | -31.24M (-2.71%) | -32.11M (-74.79%) | -127.36M (+300.38%) | -31.81M (-8.57%) | -34.79M (+9.09%) | -31.89M (-73.41%) | -119.92M (+293.18%) | -30.50M (-0.78%) | -30.74M (+16.35%) | -26.42M (-77.31%) | -116.42M (+287.68%) | -30.03M (+9.80%) | -27.35M (-11.97%) | -31.07M (-72.36%) | -112.40M (+264.23%) | -30.86M (+14.89%) | -26.86M (+26.10%) | -21.30M (-62.59%) | -56.93M (+239.68%) | -16.76M | - | - | - | - | - | - |